Applied Therapeutics Stock Current Liabilities
APLT Stock | USD 0.52 0.01 1.89% |
Applied Therapeutics fundamentals help investors to digest information that contributes to Applied Therapeutics' financial success or failures. It also enables traders to predict the movement of Applied Stock. The fundamental analysis module provides a way to measure Applied Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Applied Therapeutics stock.
At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 1.4 M in 2025, whereas Non Current Liabilities Other is likely to drop slightly above 681.3 K in 2025.
Applied | Current Liabilities |
Applied Therapeutics Company Current Liabilities Analysis
Applied Therapeutics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Applied Therapeutics Current Liabilities | 11.19 M |
Most of Applied Therapeutics' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Applied Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Applied Therapeutics is extremely important. It helps to project a fair market value of Applied Stock properly, considering its historical fundamentals such as Current Liabilities. Since Applied Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Applied Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Applied Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Applied Current Liabilities Historical Pattern
Today, most investors in Applied Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Applied Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Applied Therapeutics current liabilities as a starting point in their analysis.
Applied Therapeutics Current Liabilities |
Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Applied Total Current Liabilities
Total Current Liabilities |
|
At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year.
In accordance with the recently published financial statements, Applied Therapeutics has a Current Liabilities of 11.19 M. This is 99.36% lower than that of the Biotechnology sector and 97.94% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.86% higher than that of the company.
Applied Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Applied Therapeutics' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Applied Therapeutics could also be used in its relative valuation, which is a method of valuing Applied Therapeutics by comparing valuation metrics of similar companies.Applied Therapeutics is currently under evaluation in current liabilities category among its peers.
Applied Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Applied Therapeutics from analyzing Applied Therapeutics' financial statements. These drivers represent accounts that assess Applied Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Applied Therapeutics' important valuation drivers and their relationship over time.
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Market Cap | 483.5M | 229.1M | 28.7M | 282.2M | 254.0M | 176.7M | |
Enterprise Value | 427.8M | 176.5M | 13.0M | 233.1M | 209.8M | 152.4M |
Applied Fundamentals
Return On Equity | -4.73 | ||||
Return On Asset | -0.76 | ||||
Operating Margin | (243.80) % | ||||
Current Valuation | (36.27 M) | ||||
Shares Outstanding | 116.36 M | ||||
Shares Owned By Insiders | 5.70 % | ||||
Shares Owned By Institutions | 94.30 % | ||||
Number Of Shares Shorted | 19.71 M | ||||
Price To Earning | (7.46) X | ||||
Price To Book | 10.29 X | ||||
Price To Sales | 54.68 X | ||||
Revenue | 9.99 M | ||||
Gross Profit | (52.56 M) | ||||
EBITDA | (64.53 M) | ||||
Net Income | (119.76 M) | ||||
Cash And Equivalents | 67.72 M | ||||
Cash Per Share | 1.41 X | ||||
Total Debt | 777 K | ||||
Debt To Equity | 0.14 % | ||||
Current Ratio | 1.49 X | ||||
Book Value Per Share | 0.05 X | ||||
Cash Flow From Operations | (55.17 M) | ||||
Short Ratio | 5.08 X | ||||
Earnings Per Share | (1.42) X | ||||
Target Price | 5.5 | ||||
Number Of Employees | 37 | ||||
Beta | 1.88 | ||||
Market Capitalization | 59.36 M | ||||
Total Asset | 54.83 M | ||||
Retained Earnings | (468.59 M) | ||||
Working Capital | (16.8 M) | ||||
Current Asset | 37.74 M | ||||
Current Liabilities | 11.19 M | ||||
Net Asset | 54.83 M |
About Applied Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Applied Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.